Regen BioPharma (RGBP) Financial statements

Company Profile

Income Income Statement

Balance Balance Sheet

Cash Cash Flow

Absolute

YoY%QoQ% (e.g. Q3 vs Q2)

QoQ% (e.g. Q3 2020 vs Q3 2019)

Annual

Quarterly

		Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014
Total Revenue
Cost of Revenue
Gross Profit
Gross Profit Margin (%)
R&D Expense
SG&A Expense
Total Operating Expenses
Operating Income or Loss
Operating Margin (%)
Interest Expense
Total Other Income/Expenses
Income Before Tax
Income Tax Expense
Income from Continuing Ops.
Net Income
Net Profit Margin (%)
Net Income Available to Common Shareholders
Basic EPS
Diluted EPS
Basic Average Shares
Diluted Average Shares

		Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019
Total Revenue
Cost of Revenue
Gross Profit
Gross Profit Margin (%)
R&D Expense
SG&A Expense
Total Operating Expenses
Operating Income or Loss
Operating Margin (%)
Interest Expense
Total Other Income/Expenses
Income Before Tax
Income Tax Expense
Income from Continuing Ops.
Net Income
Net Profit Margin (%)
Net Income Available to Common Shareholders
Basic EPS
Diluted EPS
Basic Average Shares
Diluted Average Shares

		Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014
Current Assets
Cash & Cash Equivalents
Marketable Securities
Receivables
Inventories
Other Current Assets
Total Current Assets
Non-Current Assets
Marketable Securities
PPE Net
Intangibles inc. Goodwill
Other Non-Current Assets
Total Non-Current Assets
Total Assets
Current Liabilities
Accounts Payable
Deferred Revenues
Debt, Current
Accrued Liabilities
Other Current Liabilities
Total Current Liabilities
Non-Current Liabilities
Deferred Revenues
Debt, Non-Current
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
Shareholders' Equity
Common Stock
Additional Paid-In Capital
Retained Earnings
Other Shareholders' Equity
Total Shareholders' Equity
Total Liabilities & Shareholders' Equity

		Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019
Current Assets
Cash & Cash Equivalents
Marketable Securities
Receivables
Inventories
Other Current Assets
Total Current Assets
Non-Current Assets
Marketable Securities
PPE Net
Intangibles inc. Goodwill
Other Non-Current Assets
Total Non-Current Assets
Total Assets
Current Liabilities
Accounts Payable
Deferred Revenues
Debt, Current
Accrued Liabilities
Other Current Liabilities
Total Current Liabilities
Non-Current Liabilities
Deferred Revenues
Debt, Non-Current
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
Shareholders' Equity
Common Stock
Additional Paid-In Capital
Retained Earnings
Other Shareholders' Equity
Total Shareholders' Equity
Total Liabilities & Shareholders' Equity

		Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014
Cash Flows from Operating Activities
Net Income
Depreciation & Amortization
Deferred Income Taxes
Stock Based Compensation
Accounts Receivable
Inventory
Accounts Payable
Deferred Revenue
Other Non-Cash
Operating Cash Flow
Cash Flows from Investing Activities
PPE Investments
Net Acquisitions
Purchase of Investments
Sale of Investments
Other Investing Activity
Investing Cash Flow
Cash Flows from Financing Activities
Debt Issued
Proceeds from Debt Repayment
Debt Repayment
Proceeds from Sale of Equity
Equity Repurchased
Dividend Paid
Other Financing Activity
Financing Cash Flow
Cash Position
Beginning Cash Position
End Cash Position
Change in Cash
Free Cash Flow
Operating Cash Flow
Capital Expenditure
Free Cash Flow

		Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019
Cash Flows from Operating Activities
Net Income
Depreciation & Amortization
Deferred Income Taxes
Stock Based Compensation
Accounts Receivable
Inventory
Accounts Payable
Deferred Revenue
Other Non-Cash
Operating Cash Flow
Cash Flows from Investing Activities
PPE Investments
Net Acquisitions
Purchase of Investments
Sale of Investments
Other Investing Activity
Investing Cash Flow
Cash Flows from Financing Activities
Debt Issued
Proceeds from Debt Repayment
Debt Repayment
Proceeds from Sale of Equity
Equity Repurchased
Dividend Paid
Other Financing Activity
Financing Cash Flow
Cash Position
Beginning Cash Position
End Cash Position
Change in Cash
Free Cash Flow
Operating Cash Flow
Capital Expenditure
Free Cash Flow

Download data

Beta Financial statements are in beta. Read the caveats.